Source: Journal of Clinical Oncology. Conference titles: Annual Meeting of the American Society of Clinical Oncology. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (PATOLOGIA), QUALIDADE DE VIDA (AVALIAÇÃO), METÁSTASE NEOPLÁSICA
ABNT
BEATO, C. A et al. Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. alexandria: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 jun. 2024. , 2006APA
Beato, C. A., Van Eyll, B., Federico, M. H. H., Skare, N., Perdicaris, M. R., Franke, F. A., et al. (2006). Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. alexandria: Faculdade de Medicina, Universidade de São Paulo.NLM
Beato CA, Van Eyll B, Federico MHH, Skare N, Perdicaris MR, Franke FA, Oliveira C, Cabral C, Ribeiro R, Gampel O. Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. 2006 ; 24( 18S ): 489s.[citado 2024 jun. 11 ]Vancouver
Beato CA, Van Eyll B, Federico MHH, Skare N, Perdicaris MR, Franke FA, Oliveira C, Cabral C, Ribeiro R, Gampel O. Evaluation of quality of life (QoL) in 1,210 patients (pts) with metastic colorectal cancer (MCRC) treated with capecitabine (X) in Brazil: udated results from a large pt cohort with analysis a function of pts'ECOG PS. Journal of Clinical Oncology. 2006 ; 24( 18S ): 489s.[citado 2024 jun. 11 ]